RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors (Q36693087)
Jump to navigation
Jump to search
scientific article published on 29 October 2015
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors |
scientific article published on 29 October 2015 |
Statements
1 reference
RAS/MAPK Activation Is Associated with Reduced Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancer: Therapeutic Cooperation Between MEK and PD-1/PD-L1 Immune Checkpoint Inhibitors (English)
1 reference
Justin M Balko
1 reference
Simon A Mallal
1 reference
Paul A Beavis
1 reference
Sathana Dushyanthen
1 reference
Roberto Salgado
1 reference
Carsten Denkert
1 reference
Peter Savas
1 reference
Susan Combs
1 reference
David L Rimm
1 reference
Jennifer M Giltnane
1 reference
Violeta Sánchez
1 reference
Melinda E Sanders
1 reference
Rebecca S Cook
1 reference
Mark A Pilkinton
1 reference
Kai Wang
1 reference
Vincent A Miller
1 reference
Phil J Stephens
1 reference
Roman Yelensky
1 reference
Franco D Doimi
1 reference
Sergey V Ryzhov
1 reference
Carlos L Arteaga
1 reference
1 reference
Identifiers
1 reference